Global Drug Discovery Market By Drug Type (Small Molecule, & Large Molecule), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology & Other Technologies), By End-Use (Pharmaceutical Companies, Contract Research Organizations, & Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2033

Published date: Oct 2024
Report ID: 130005
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Drug Discovery Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Drug Discovery Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Drug Discovery Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 3.3. Global Drug Discovery Market Attractiveness Analysis, By Drug Type
    3.3.1. Small Molecule
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Large Molecule
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
  - 3.4. Global Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 3.5. Global Drug Discovery Market Attractiveness Analysis, By Technology
    3.5.1. High Throughput Screening
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Pharmacogenomics
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Combinatorial Chemistry
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
    3.5.4. Nanotechnology
    3.5.4.1. Insights
    3.5.4.2. Key Takeaways
    3.5.5. Other Technologies
    3.5.5.1. Insights
    3.5.5.2. Key Takeaways
  - 3.6. Global Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 3.7. Global Drug Discovery Market Attractiveness Analysis, By End-use
    3.7.1. Pharmaceutical Companies
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Contract Research Organizations
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Others
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
- 4. Global Drug Discovery Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Drug Discovery Market Attractiveness Analysis, By Region
- 5. North America Drug Discovery Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 5.3. North America Drug Discovery Market Attractiveness Analysis, By Drug Type
  - 5.4. North America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 5.5. North America Drug Discovery Market Attractiveness Analysis, By Technology
  - 5.6. North America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 5.7. North America Drug Discovery Market Attractiveness Analysis, By End-use
  - 5.8. North America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.9. North America Drug Discovery Market Attractiveness Analysis, By Country
    5.9.1. The US
    5.9.2. Canada
- 6. Europe Drug Discovery Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 6.3. Europe Drug Discovery Market Attractiveness Analysis, By Drug Type
  - 6.4. Europe Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 6.5. Europe Drug Discovery Market Attractiveness Analysis, By Technology
  - 6.6. Europe Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 6.7. Europe Drug Discovery Market Attractiveness Analysis, By End-use
  - 6.8. Europe Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.9. Europe Drug Discovery Market Attractiveness Analysis, By Country
    6.9.1. Germany
    6.9.2. The UK
    6.9.3. France
    6.9.4. Spain
    6.9.5. Italy
    6.9.6. Russia
    6.9.7. Netherland
    6.9.8. Rest of Europe
- 7. Asia Pacific Drug Discovery Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 7.3. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Drug Type
  - 7.4. Asia Pacific Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 7.5. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Technology
  - 7.6. Asia Pacific Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 7.7. Asia Pacific Drug Discovery Market Attractiveness Analysis, By End-use
  - 7.8. Asia Pacific Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.9. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Country
    7.9.1. China
    7.9.2. Japan
    7.9.3. South Korea
    7.9.4. India
    7.9.5. Australia
    7.9.6. New Zealand
    7.9.7. Singapore
    7.9.8. Thailand
    7.9.9. Vietnam
    7.9.10. Rest of Asia Pacific
- 8. Latin America Drug Discovery Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 8.3. Latin America Drug Discovery Market Attractiveness Analysis, By Drug Type
  - 8.4. Latin America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 8.5. Latin America Drug Discovery Market Attractiveness Analysis, By Technology
  - 8.6. Latin America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 8.7. Latin America Drug Discovery Market Attractiveness Analysis, By End-use
  - 8.8. Latin America Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.9. Latin America Drug Discovery Market Attractiveness Analysis, By Country
    8.9.1. Brazil
    8.9.2. Mexico
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Drug Discovery Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Type, 2019-2033
  - 9.3. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Drug Type
  - 9.4. Middle East & Africa Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
  - 9.5. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Technology
  - 9.6. Middle East & Africa Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 9.7. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By End-use
  - 9.8. Middle East & Africa Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.9. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Country
    9.9.1. South Africa
    9.9.2. Saudi Arabia
    9.9.3. UAE
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Hoffmann-La Roche Ltd
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Bayer AG
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Abbott Laboratories Inc.
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Shimadzu Corp
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Eli Lilly and Company
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. AstraZeneca
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Sanofi
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Pfizer Inc.
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. GlaxoSmithKline PLC
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Merck and Co. Inc.
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
    10.7.11. Agilent Technologies Inc.
    10.7.11.1. Company Details
    10.7.11.2. Business Overview
    10.7.11.3. Product Portfolio
    10.7.11.4. Financial Insights
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6. SWOT Analysis
    10.7.11.7. Geographic Footprint
    10.7.12. Polpharma Biologics Group
    10.7.12.1. Company Details
    10.7.12.2. Business Overview
    10.7.12.3. Product Portfolio
    10.7.12.4. Financial Insights
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.12.6. SWOT Analysis
    10.7.12.7. Geographic Footprint
    10.7.13. Novartis AG
    10.7.13.1. Company Details
    10.7.13.2. Business Overview
    10.7.13.3. Product Portfolio
    10.7.13.4. Financial Insights
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.13.6. SWOT Analysis
    10.7.13.7. Geographic Footprint
    10.7.14. Takeda Pharmaceutical Company Limited.
    10.7.14.1. Company Details
    10.7.14.2. Business Overview
    10.7.14.3. Product Portfolio
    10.7.14.4. Financial Insights
    10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.14.6. SWOT Analysis
    10.7.14.7. Geographic Footprint
    10.7.15. Teva Pharmaceutical Industries Ltd.
    10.7.15.1. Company Details
    10.7.15.2. Business Overview
    10.7.15.3. Product Portfolio
    10.7.15.4. Financial Insights
    10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.15.6. SWOT Analysis
    10.7.15.7. Geographic Footprint
    10.7.16. Other Key Players
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 2. Global Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 3. Global Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 4. Global Drug Discovery Market Value (US$ Mn), By Region, 2019-2033
- Table 5. North America Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 6. North America Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 7. North America Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 8. North America Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 9. The US Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 10. The US Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 11. The US Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 12. Canada Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 13. Canada Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 14. Canada Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 15. Europe Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 16. Europe Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 17. Europe Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 18. Europe Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 19. Germany Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 20. Germany Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 21. Germany Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 22. The UK Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 23. The UK Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 24. The UK Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 25. France Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 26. France Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 27. France Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 28. Spain Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 29. Spain Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 30. Spain Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 31. Italy Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 32. Italy Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 33. Italy Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 34. Russia Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 35. Russia Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 36. Russia Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 37. Netherland Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 38. Netherland Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 39. Netherland Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 40. Rest of Europe Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 41. Rest of Europe Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 42. Rest of Europe Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 43. Asia Pacific Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 44. Asia Pacific Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 45. Asia Pacific Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 46. Asia Pacific Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 47. China Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 48. China Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 49. China Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 50. India Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 51. India Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 52. India Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 53. Japan Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 54. Japan Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 55. Japan Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 56. South Korea Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 57. South Korea Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 58. South Korea Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 59. Australia Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 60. Australia Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 61. Australia Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 62. New Zealand Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 63. New Zealand Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 64. New Zealand Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 65. Singapore Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 66. Singapore Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 67. Singapore Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 68. Thailand Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 69. Thailand Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 70. Thailand Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 71. Vietnam Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 72. Vietnam Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 73. Vietnam Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 74. Rest of Asia Pacific Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 75. Rest of Asia Pacific Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 76. Rest of Asia Pacific Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 77. Latin America Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 78. Latin America Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 79. Latin America Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 80. Latin America Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 81. Brazil Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 82. Brazil Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 83. Brazil Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 84. Mexico Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 85. Mexico Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 86. Mexico Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 87. Rest of Latin America Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 88. Rest of Latin America Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 89. Rest of Latin America Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 90. Middle East & Africa Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 91. Middle East & Africa Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 92. Middle East & Africa Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 93. Middle East & Africa Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 94. South Africa Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 95. South Africa Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 96. South Africa Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 97. Saudi Arabia Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 98. Saudi Arabia Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 99. Saudi Arabia Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 100. UAE Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 101. UAE Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 102. UAE Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
- Table 103. Rest of Middle East & Africa Drug Discovery Market Value (US$ Mn), By Drug Type, 2019-2033
- Table 104. Rest of Middle East & Africa Drug Discovery Market Value (US$ Mn), By Technology, 2019-2033
- Table 105. Rest of Middle East & Africa Drug Discovery Market Value (US$ Mn), By End-use, 2019-2033
List of Figures
- Figure 1. Global Drug Discovery Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Drug Discovery Market
- Figure 5. Global Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 6. Global Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 7. Global Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 8. Global Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 9. Global Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 10. Global Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 11. Global Drug Discovery Market Analysis, By Region, 2019, 2023 and 2033
- Figure 12. Global Drug Discovery Market Attractiveness Analysis, By Region
- Figure 13. North America Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 14. North America Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 15. North America Drug Discovery Market (US$ Mn), by Small Molecule, 2019-2033
- Figure 16. North America Drug Discovery Market (US$ Mn), by Large Molecule, 2019-2033
- Figure 17. North America Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 18. North America Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 19. North America Drug Discovery Market (US$ Mn), by High Throughput Screening, 2019-2033
- Figure 20. North America Drug Discovery Market (US$ Mn), by Pharmacogenomics, 2019-2033
- Figure 21. North America Drug Discovery Market (US$ Mn), by Combinatorial Chemistry, 2019-2033
- Figure 22. North America Drug Discovery Market (US$ Mn), by Nanotechnology, 2019-2033
- Figure 23. North America Drug Discovery Market (US$ Mn), by Other Technologies, 2019-2033
- Figure 24. North America Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 25. North America Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 26. North America Drug Discovery Market (US$ Mn), by Pharmaceutical Companies, 2019-2033
- Figure 27. North America Drug Discovery Market (US$ Mn), by Contract Research Organizations, 2019-2033
- Figure 28. North America Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 29. North America Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 30. North America Drug Discovery Market Attractiveness Analysis, By Country
- Figure 31. Europe Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 32. Europe Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 33. Europe Drug Discovery Market (US$ Mn), by Small Molecule, 2019-2033
- Figure 34. Europe Drug Discovery Market (US$ Mn), by Large Molecule, 2019-2033
- Figure 35. Europe Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 36. Europe Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 37. Europe Drug Discovery Market (US$ Mn), by High Throughput Screening, 2019-2033
- Figure 38. Europe Drug Discovery Market (US$ Mn), by Pharmacogenomics, 2019-2033
- Figure 39. Europe Drug Discovery Market (US$ Mn), by Combinatorial Chemistry, 2019-2033
- Figure 40. Europe Drug Discovery Market (US$ Mn), by Nanotechnology, 2019-2033
- Figure 41. Europe Drug Discovery Market (US$ Mn), by Other Technologies, 2019-2033
- Figure 42. Europe Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 43. Europe Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 44. Europe Drug Discovery Market (US$ Mn), by Pharmaceutical Companies, 2019-2033
- Figure 45. Europe Drug Discovery Market (US$ Mn), by Contract Research Organizations, 2019-2033
- Figure 46. Europe Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 47. Europe Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 48. Europe Drug Discovery Market Attractiveness Analysis, By Country
- Figure 49. Asia Pacific Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 50. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 51. Asia Pacific Drug Discovery Market (US$ Mn), by Small Molecule, 2019-2033
- Figure 52. Asia Pacific Drug Discovery Market (US$ Mn), by Large Molecule, 2019-2033
- Figure 53. Asia Pacific Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 54. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 55. Asia Pacific Drug Discovery Market (US$ Mn), by High Throughput Screening, 2019-2033
- Figure 56. Asia Pacific Drug Discovery Market (US$ Mn), by Pharmacogenomics, 2019-2033
- Figure 57. Asia Pacific Drug Discovery Market (US$ Mn), by Combinatorial Chemistry, 2019-2033
- Figure 58. Asia Pacific Drug Discovery Market (US$ Mn), by Nanotechnology, 2019-2033
- Figure 59. Asia Pacific Drug Discovery Market (US$ Mn), by Other Technologies, 2019-2033
- Figure 60. Asia Pacific Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 61. Asia Pacific Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 62. Asia Pacific Drug Discovery Market (US$ Mn), by Pharmaceutical Companies, 2019-2033
- Figure 63. Asia Pacific Drug Discovery Market (US$ Mn), by Contract Research Organizations, 2019-2033
- Figure 64. Asia Pacific Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 65. Asia Pacific Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 66. Asia Pacific Drug Discovery Market Attractiveness Analysis, By Country
- Figure 67. Latin America Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 68. Latin America Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 69. Latin America Drug Discovery Market (US$ Mn), by Small Molecule, 2019-2033
- Figure 70. Latin America Drug Discovery Market (US$ Mn), by Large Molecule, 2019-2033
- Figure 71. Latin America Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 72. Latin America Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 73. Latin America Drug Discovery Market (US$ Mn), by High Throughput Screening, 2019-2033
- Figure 74. Latin America Drug Discovery Market (US$ Mn), by Pharmacogenomics, 2019-2033
- Figure 75. Latin America Drug Discovery Market (US$ Mn), by Combinatorial Chemistry, 2019-2033
- Figure 76. Latin America Drug Discovery Market (US$ Mn), by Nanotechnology, 2019-2033
- Figure 77. Latin America Drug Discovery Market (US$ Mn), by Other Technologies, 2019-2033
- Figure 78. Latin America Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 79. Latin America Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 80. Latin America Drug Discovery Market (US$ Mn), by Pharmaceutical Companies, 2019-2033
- Figure 81. Latin America Drug Discovery Market (US$ Mn), by Contract Research Organizations, 2019-2033
- Figure 82. Latin America Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 83. Latin America Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 84. Latin America Drug Discovery Market Attractiveness Analysis, By Country
- Figure 85. Middle East & Africa Drug Discovery Market Analysis, By Drug Type, 2019, 2023 and 2033
- Figure 86. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Drug Type
- Figure 87. Middle East & Africa Drug Discovery Market (US$ Mn), by Small Molecule, 2019-2033
- Figure 88. Middle East & Africa Drug Discovery Market (US$ Mn), by Large Molecule, 2019-2033
- Figure 89. Middle East & Africa Drug Discovery Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 90. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Technology
- Figure 91. Middle East & Africa Drug Discovery Market (US$ Mn), by High Throughput Screening, 2019-2033
- Figure 92. Middle East & Africa Drug Discovery Market (US$ Mn), by Pharmacogenomics, 2019-2033
- Figure 93. Middle East & Africa Drug Discovery Market (US$ Mn), by Combinatorial Chemistry, 2019-2033
- Figure 94. Middle East & Africa Drug Discovery Market (US$ Mn), by Nanotechnology, 2019-2033
- Figure 95. Middle East & Africa Drug Discovery Market (US$ Mn), by Other Technologies, 2019-2033
- Figure 96. Middle East & Africa Drug Discovery Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 97. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By End-use
- Figure 98. Middle East & Africa Drug Discovery Market (US$ Mn), by Pharmaceutical Companies, 2019-2033
- Figure 99. Middle East & Africa Drug Discovery Market (US$ Mn), by Contract Research Organizations, 2019-2033
- Figure 100. Middle East & Africa Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 101. Middle East & Africa Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 102. Middle East & Africa Drug Discovery Market Attractiveness Analysis, By Country
- Hoffmann-La Roche Ltd
- Bayer AG Company Profile
- Abbott Laboratories Inc.
- Shimadzu Corp
- Eli Lilly and Company
- AstraZeneca Plc Company Profile
- Sanofi Company Profile
- Pfizer Inc Company Profile
- GlaxoSmithKline PLC
- Merck and Co. Inc.
- Agilent Technologies Inc. Company Profile
- Polpharma Biologics Group
- Novartis AG Company Profile
- Takeda Pharmaceutical Company Limited.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients